EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions

Karolina Louvanto iD, Lisanne Verhoef iD, Ville Pimenoff iD, Tiina Eriksson, Siiri Leppälä, Camilla Lagheden, Penelope Gray iD, Dorota Scibior-Bentkowska, Elizabeth Sumiec, Pekka Nieminen, Joakim Dillner iD, Johannes Berkhof und 4 weitere

International Journal of Cancer · 2024-11 · 155 (9) · 1549-1557

DOI: 10.1002/ijc.35044 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Cancer, online erschienen am 27.05.2024. Verfasst von Karolina Louvanto und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: DNA Methylation, Uterine Cervical Neoplasms, Papillomavirus Vaccines, Papillomavirus Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer screening programs, including triage tests, need redesigning as human papillomavirus (HPV)‐vaccinated women are entering the programs. Methylation markers offer a potential solution to reduce false‐positive rates by identifying clinically relevant cervical lesions with progressive potential. In a nested case–control study, 9242 women who received the three‐dose HPV16/18‐vaccine at ages 12–15 or 18 in a community‐randomized trial were included. Subsequently, they were re‐randomized for either frequent or infrequent cervical cancer screening trials. Over a 15‐year post‐vaccination follow‐up until 2022, 17 high‐grade squamous intraepithelial lesion (HSIL) and 15 low‐grade (LSIL) cases were identified at the 25‐year screening round, alongside 371 age and community‐matched HPV16/18‐vaccinated controls. Methylation analyses were performed on cervical samples collected at age 25, preceding histologically confirmed LSIL or HSIL diagnoses. DNA methylation of viral (HPV16/18/31/33) and host‐cell genes ( EPB41L3 , FAM19A4 , and miR124‐2) was measured, along with HPV‐genotyping. No HPV16/18 HSIL cases were observed. The predominant HPV‐genotypes were HPV52 (29.4%), HPV59/HPV51/HPV58 (each 23.5%), and HPV33 (17.7%). Methylation levels were generally low, with no significant differences in mean methylation levels of viral or host‐cell genes between the LSIL/HSIL and controls. However, a significant difference in methylation levels was found between HSIL cases and controls when considering a combination of viral genes and EPB41L3 ( p value = .0001). HPV‐vaccinated women with HSIL had HPV infections with uncommon HPV types that very rarely cause cancer and displayed low methylation levels. Further investigation is warranted to understand the likely regressive nature of HSIL among HPV‐vaccinated women and its implications for management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationUterine Cervical NeoplasmsPapillomavirus VaccinesPapillomavirus InfectionsHumansFemaleAdultCase-Control StudiesEarly Detection of CancerAdolescentMicroRNAsHuman papillomavirus 16Squamous Intraepithelial LesionsChildUterine Cervical DysplasiaYoung AdultSquamous Intraepithelial Lesions of the CervixHuman papillomavirus 18Biomarkers, TumorVaccinationHuman Papillomavirus VirusesCytokines

Stichwörter der Autor:innen

high‐grade squamous intraepithelial lesionhuman papillomavirusmethylationscreeningvaccination

Substanzen

Papillomavirus VaccinesMicroRNAsMIRN124 microRNA, humanTAFA4 protein, humanBiomarkers, TumorCytokines

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
  • Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Unit of Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institute, Stockholm, Sweden.
  • Centre for Cancer Screening, Prevention and Early Detection (SPED), Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

ORCID-Profile: Karolina Louvanto, Lisanne Verhoef, Ville Pimenoff, Penelope Gray, Joakim Dillner, Matti Lehtinen

Förderung

  • European Union's Horizon 2020 research and innovation program

Zitieren

APA

Louvanto, K., Verhoef, L., Pimenoff, V., Eriksson, T., Leppälä, S., Lagheden, C., Gray, P., Scibior-Bentkowska, D., Sumiec, E., Nieminen, P., Dillner, J., Berkhof, J., Meijer, C. J. L. M., Lehtinen, M., Nedjai, B., & Heideman, D. A. M. (2024). Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions. International Journal of Cancer, 155(9), 1549-1557. https://doi.org/10.1002/ijc.35044

Vancouver

Louvanto K, Verhoef L, Pimenoff V, Eriksson T, Leppälä S, Lagheden C, et al. Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions. International Journal of Cancer. 2024;155(9):1549-1557. doi:10.1002/ijc.35044

BibTeX
@article{Louvanto2024,
  author = {Louvanto, Karolina and Verhoef, Lisanne and Pimenoff, Ville and Eriksson, Tiina and Leppälä, Siiri and Lagheden, Camilla and Gray, Penelope and Scibior-Bentkowska, Dorota and Sumiec, Elizabeth and Nieminen, Pekka and Dillner, Joakim and Berkhof, Johannes and Meijer, Chris J L M and Lehtinen, Matti and Nedjai, Belinda and Heideman, Daniëlle A M},
  title = {Low methylation marker levels among human papillomavirus‐vaccinated women with cervical high‐grade squamous intraepithelial lesions},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {155},
  number = {9},
  pages = {1549--1557},
  doi = {10.1002/ijc.35044}
}
Kostenlos starten →